Search research articles
Contact Us
Filters
Showing results (21-30 of 225) with videos related to
Page
of 23
Sort By:
Revue Medicale Suisse
|
November 20, 2013
[Management of post-coital bleeding: should all women be referred?]
Jean Dubuisson, Meriem Boukrid, Patrick Petignat
Acta Cytologica
|
November 15, 2017
Use of Automated Analysis of Cervical Cytology for the Detection of High-Grade Squamous Intraepithelial Lesions in Human Papillomavirus-Positive Women: A Future Practice?
Pierre Vassilakos, Rosa Catarino, Patrick Petignat
Revue Medicale Suisse
|
November 22, 2012
[Cervical cancer prevention in Switzerland: the challenges of the vaccine era]
Pierre Vassilakos, Sarah Untiet, Patrick Petignat
Oncoscience
|
May 14, 2023
UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?
Melisa Husein, Patrick Petignat, Marie Cohen
Revue Medicale Suisse
|
October 24, 2019
Patrick Petignat, Isabelle Streuli, Patrice Mathevet
Human Reproduction (Oxford, England)
|
June 4, 2002
Are fertility drugs a risk factor for persistent trophoblastic tumour?
Patrick Petignat, Pierre Vassilakos, Aldo Campana
Targeted Oncology
|
October 24, 2012
GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78
Florence Delie, Patrick Petignat, Marie Cohen
Obstetrics and Gynecology
|
September 10, 2003
Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation
Patrick Petignat, Michel Boulvain, Pierre Vassilakos
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
August 6, 2004
Influence of misoprostol or prostaglandin E(2) for induction of labor on the incidence of pathological CTG tracing: a randomized trial
Alexandre Megalo, Patrick Petignat, Patrick Hohlfeld
Swiss Medical Weekly
|
September 6, 2012
How to improve cervical cancer screening in Switzerland?
Patrick Petignat, Sarah Untiet, Pierre Vassilakos
Page
of 23
Search research articles
Search
Showing results (21-30 of 225) with videos related to
Sort By:
Page
of 23
Revue Medicale Suisse
|
November 20, 2013
[Management of post-coital bleeding: should all women be referred?]
Jean Dubuisson, Meriem Boukrid, Patrick Petignat
Acta Cytologica
|
November 15, 2017
Use of Automated Analysis of Cervical Cytology for the Detection of High-Grade Squamous Intraepithelial Lesions in Human Papillomavirus-Positive Women: A Future Practice?
Pierre Vassilakos, Rosa Catarino, Patrick Petignat
Revue Medicale Suisse
|
November 22, 2012
[Cervical cancer prevention in Switzerland: the challenges of the vaccine era]
Pierre Vassilakos, Sarah Untiet, Patrick Petignat
Oncoscience
|
May 14, 2023
UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?
Melisa Husein, Patrick Petignat, Marie Cohen
Revue Medicale Suisse
|
October 24, 2019
Patrick Petignat, Isabelle Streuli, Patrice Mathevet
Human Reproduction (Oxford, England)
|
June 4, 2002
Are fertility drugs a risk factor for persistent trophoblastic tumour?
Patrick Petignat, Pierre Vassilakos, Aldo Campana
Targeted Oncology
|
October 24, 2012
GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78
Florence Delie, Patrick Petignat, Marie Cohen
Obstetrics and Gynecology
|
September 10, 2003
Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation
Patrick Petignat, Michel Boulvain, Pierre Vassilakos
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
August 6, 2004
Influence of misoprostol or prostaglandin E(2) for induction of labor on the incidence of pathological CTG tracing: a randomized trial
Alexandre Megalo, Patrick Petignat, Patrick Hohlfeld
Swiss Medical Weekly
|
September 6, 2012
How to improve cervical cancer screening in Switzerland?
Patrick Petignat, Sarah Untiet, Pierre Vassilakos
Page
of 23